Shanghai Huali Bio-Pharmaceutical

Shanghai Huali Bio-Pharmaceutical is a high-tech enterprise focused on the research, development, and industrialization of biopharmaceuticals and high-end chemical drugs. Founded with strong ties to the East China University of Science and Technology, the company specializes in peptide drugs and recombinant protein technologies. Its product portfolio includes treatments for metabolic diseases and cardiovascular conditions, with a notable focus on GLP-1 receptor agonists and anticoagulants. The company operates integrated R&D and manufacturing facilities that comply with GMP standards to support both domestic and international markets.